NEW HAVEN — Medicare officials are reminding recipients that decisions on what plans are best for their individual situations need to be made within a longer, but earlier, time-frame this year.
There are also more benefits, choices and reduced costs connected to the plans, and a rating system on the health plans and the 30 Medicare Advantage drug options.
Traditionally, the annual decisions on the plans were made later in the year. This year, the window in which to make a choice was extended to seven weeks, beginning Oct. 15, but ending Dec. 7.
Dr. Jaye Weisman, regional director for the Centers for Medicare & Medicaid Services, in a phone interview Friday, said that the cost of the Part D drug options range from $15.10 a month for Humana Walmart-Preferred to $110.20 for Humana Complete.
The new public rating system goes from 1 star, which indicates poor quality, to 5 stars for excellent quality.
Read More.
No comments:
Post a Comment